224 related articles for article (PubMed ID: 32386395)
1. Δ
Adam KCS; Doss MK; Pabon E; Vogel EK; de Wit H
Neuropsychopharmacology; 2020 Oct; 45(11):1807-1816. PubMed ID: 32386395
[TBL] [Abstract][Full Text] [Related]
2. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study.
Mathai DS; Holst M; Rodgman C; Haile CN; Keller J; Hussain MZ; Kosten TR; Newton TF; Verrico CD
J Neuropsychiatry Clin Neurosci; 2018; 30(1):66-76. PubMed ID: 28641496
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS
Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290
[TBL] [Abstract][Full Text] [Related]
4. The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial.
Englund A; Atakan Z; Kralj A; Tunstall N; Murray R; Morrison P
J Psychopharmacol; 2016 Feb; 30(2):140-51. PubMed ID: 26577065
[TBL] [Abstract][Full Text] [Related]
5. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
Curran HV; Brignell C; Fletcher S; Middleton P; Henry J
Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
[TBL] [Abstract][Full Text] [Related]
6. Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.
D'Souza DC; Braley G; Blaise R; Vendetti M; Oliver S; Pittman B; Ranganathan M; Bhakta S; Zimolo Z; Cooper T; Perry E
Psychopharmacology (Berl); 2008 Jul; 198(4):587-603. PubMed ID: 18228005
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Cannabidiol and δ-9-Tetrahydrocannabinol in Social Cognition: A Naturalistic Controlled Study.
Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
Cannabis Cannabinoid Res; 2024 Feb; 9(1):230-240. PubMed ID: 35881851
[No Abstract] [Full Text] [Related]
8. The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment.
Lawn W; Trinci K; Mokrysz C; Borissova A; Ofori S; Petrilli K; Bloomfield M; Haniff ZR; Hall D; Fernandez-Vinson N; Wang S; Englund A; Chesney E; Wall MB; Freeman TP; Curran HV
Addiction; 2023 Jul; 118(7):1282-1294. PubMed ID: 36750134
[TBL] [Abstract][Full Text] [Related]
9. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).
Hunault CC; Mensinga TT; Böcker KB; Schipper CM; Kruidenier M; Leenders ME; de Vries I; Meulenbelt J
Psychopharmacology (Berl); 2009 May; 204(1):85-94. PubMed ID: 19099294
[TBL] [Abstract][Full Text] [Related]
10. Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function.
Morgan CJA; Freeman TP; Hindocha C; Schafer G; Gardner C; Curran HV
Transl Psychiatry; 2018 Sep; 8(1):181. PubMed ID: 30185793
[TBL] [Abstract][Full Text] [Related]
11. The "Next Day" Effects of Cannabis Use: A Systematic Review.
McCartney D; Suraev A; McGregor IS
Cannabis Cannabinoid Res; 2023 Feb; 8(1):92-114. PubMed ID: 36475998
[No Abstract] [Full Text] [Related]
12. Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences.
Tunbridge EM; Dunn G; Murray RM; Evans N; Lister R; Stumpenhorst K; Harrison PJ; Morrison PD; Freeman D
J Psychopharmacol; 2015 Nov; 29(11):1146-51. PubMed ID: 26464454
[TBL] [Abstract][Full Text] [Related]
13. Nabilone Impairs Spatial and Verbal Working Memory in Healthy Volunteers.
Kassim FM; Tod S; Rodger J; Hood SD; Lee JWY; Albrecht MA; Martin-Iverson MT
Cannabis Cannabinoid Res; 2024 Feb; 9(1):199-211. PubMed ID: 36201240
[No Abstract] [Full Text] [Related]
14. Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys.
Verrico CD; Mathai DS; Gu H; Sampson AR; Lewis DA
J Psychopharmacol; 2020 Feb; 34(2):211-220. PubMed ID: 31621487
[TBL] [Abstract][Full Text] [Related]
15. [Effects of oral cannabis and dronabinol on driving capacity].
Giroud C; Augsburger M; Favrat B; Menetrey A; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mathieu S; Castella V; Hazekamp A; Mangin P
Ann Pharm Fr; 2006 May; 64(3):161-72. PubMed ID: 16710114
[TBL] [Abstract][Full Text] [Related]
16. Delta-9-tetrahydrocannabinol intoxication is associated with increased prefrontal activation as assessed with functional near-infrared spectroscopy: A report of a potential biomarker of intoxication.
Gilman JM; Yücel MA; Pachas GN; Potter K; Levar N; Broos H; Manghis EM; Schuster RM; Evins AE
Neuroimage; 2019 Aug; 197():575-585. PubMed ID: 31075393
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV
Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information.
Ranganathan M; Radhakrishnan R; Addy PH; Schnakenberg-Martin AM; Williams AH; Carbuto M; Elander J; Pittman B; Andrew Sewell R; Skosnik PD; D'Souza DC
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):176-183. PubMed ID: 28642081
[TBL] [Abstract][Full Text] [Related]
19. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis: A Randomized Clinical Trial.
Marcotte TD; Umlauf A; Grelotti DJ; Sones EG; Mastropietro KF; Suhandynata RT; Huestis MA; Grant I; Fitzgerald RL
JAMA Psychiatry; 2023 Sep; 80(9):914-923. PubMed ID: 37531115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
